基于美国心脏病学会/美国心脏协会冠状动脉病变分类的经皮冠状动脉介入治疗 14 年来的结果 - 墨尔本介入治疗小组 (MIG) 登记。

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Cardiovascular Revascularization Medicine Pub Date : 2024-12-01 DOI:10.1016/j.carrev.2024.06.010
Pouya Nezafati , Andrew Ajani , Diem Dinh , Angela Brennan , David Clark , Christopher M. Reid , Chin Hiew , Melanie Freeman , Dion Stub , Jaya Chandrasekhar , Anand Sharma , Ernesto Oqueli
{"title":"基于美国心脏病学会/美国心脏协会冠状动脉病变分类的经皮冠状动脉介入治疗 14 年来的结果 - 墨尔本介入治疗小组 (MIG) 登记。","authors":"Pouya Nezafati ,&nbsp;Andrew Ajani ,&nbsp;Diem Dinh ,&nbsp;Angela Brennan ,&nbsp;David Clark ,&nbsp;Christopher M. Reid ,&nbsp;Chin Hiew ,&nbsp;Melanie Freeman ,&nbsp;Dion Stub ,&nbsp;Jaya Chandrasekhar ,&nbsp;Anand Sharma ,&nbsp;Ernesto Oqueli","doi":"10.1016/j.carrev.2024.06.010","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The American College of Cardiology / American Heart Association (ACC/AHA) introduced a coronary lesion classification in 1988 to stratify coronary lesions for probability of procedural success and complications after coronary angioplasty. Our aim is to assess the validity of the ACC/AHA lesion classification in predicting outcomes of percutaneous coronary intervention (PCI) in a contemporary cohort of patients.</div></div><div><h3>Methods</h3><div>Consecutive PCI procedures performed between 2005 and 2018, were divided into three periods. At each period, the ACC/AHA lesion classification (A, B1, B2, C) was analysed with respect to procedural characteristics, in-hospital and 30-day outcomes, as well as long-term mortality by linkage to the National Death Index (NDI).</div></div><div><h3>Results</h3><div>In total, 21,437 lesions were included with 7399 lesions (2005–2009), 6917 lesions (2010–2014) and 7121 lesions (2015–2018). There was a progressive increase in the number of complex lesions treated over time with ACC/AHA type C (15 %, 21 % and 26 %, <em>p</em> &lt; 0.01). The rate of PCI procedural success decreased with increase in the complexity of lesions treated across all three periods (p &lt; 0.01). Further, in-hospital and 30-day major adverse cardiovascular events (MACE), major adverse cardiac and cerebrovascular events (MACCE) increased across all three time periods (all <em>p</em> &lt; 0.05).</div></div><div><h3>Conclusions</h3><div>Our study validates the ACC/AHA lesion classification as a meaningful tool for prediction of PCI outcomes. Despite advances in PCI techniques and technology, complex lesion PCI defined by this classification continues to be associated with adverse outcomes.</div></div>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":"69 ","pages":"Pages 52-59"},"PeriodicalIF":1.6000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Percutaneous coronary intervention outcomes based on American College of Cardiology/American Heart Association coronary lesion classification over 14 years – Melbourne interventional group (MIG) registry\",\"authors\":\"Pouya Nezafati ,&nbsp;Andrew Ajani ,&nbsp;Diem Dinh ,&nbsp;Angela Brennan ,&nbsp;David Clark ,&nbsp;Christopher M. Reid ,&nbsp;Chin Hiew ,&nbsp;Melanie Freeman ,&nbsp;Dion Stub ,&nbsp;Jaya Chandrasekhar ,&nbsp;Anand Sharma ,&nbsp;Ernesto Oqueli\",\"doi\":\"10.1016/j.carrev.2024.06.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>The American College of Cardiology / American Heart Association (ACC/AHA) introduced a coronary lesion classification in 1988 to stratify coronary lesions for probability of procedural success and complications after coronary angioplasty. Our aim is to assess the validity of the ACC/AHA lesion classification in predicting outcomes of percutaneous coronary intervention (PCI) in a contemporary cohort of patients.</div></div><div><h3>Methods</h3><div>Consecutive PCI procedures performed between 2005 and 2018, were divided into three periods. At each period, the ACC/AHA lesion classification (A, B1, B2, C) was analysed with respect to procedural characteristics, in-hospital and 30-day outcomes, as well as long-term mortality by linkage to the National Death Index (NDI).</div></div><div><h3>Results</h3><div>In total, 21,437 lesions were included with 7399 lesions (2005–2009), 6917 lesions (2010–2014) and 7121 lesions (2015–2018). There was a progressive increase in the number of complex lesions treated over time with ACC/AHA type C (15 %, 21 % and 26 %, <em>p</em> &lt; 0.01). The rate of PCI procedural success decreased with increase in the complexity of lesions treated across all three periods (p &lt; 0.01). Further, in-hospital and 30-day major adverse cardiovascular events (MACE), major adverse cardiac and cerebrovascular events (MACCE) increased across all three time periods (all <em>p</em> &lt; 0.05).</div></div><div><h3>Conclusions</h3><div>Our study validates the ACC/AHA lesion classification as a meaningful tool for prediction of PCI outcomes. Despite advances in PCI techniques and technology, complex lesion PCI defined by this classification continues to be associated with adverse outcomes.</div></div>\",\"PeriodicalId\":47657,\"journal\":{\"name\":\"Cardiovascular Revascularization Medicine\",\"volume\":\"69 \",\"pages\":\"Pages 52-59\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular Revascularization Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1553838924005402\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Revascularization Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1553838924005402","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:美国心脏病学会/美国心脏协会(ACC/AHA)于1988年推出了冠状动脉病变分类法,用于对冠状动脉病变进行分层,以确定冠状动脉血管成形术后的手术成功概率和并发症。我们的目的是评估 ACC/AHA 病变分类在预测当代患者队列中经皮冠状动脉介入治疗(PCI)结果的有效性:2005年至2018年期间进行的连续PCI手术分为三个时期。在每个时期,分析ACC/AHA病变分类(A、B1、B2、C)与手术特征、院内和30天预后的关系,以及与国家死亡指数(NDI)相关联的长期死亡率:共纳入 21437 例病变,其中 7399 例(2005-2009 年)、6917 例(2010-2014 年)和 7121 例(2015-2018 年)。随着时间的推移,采用ACC/AHA C型治疗的复杂病变数量逐渐增加(15%、21%和26%,P 结论:我们的研究验证了ACC/AHA C型的有效性:我们的研究验证了 ACC/AHA 病变分类是预测 PCI 结果的有效工具。尽管 PCI 技术和科技不断进步,但根据该分类定义的复杂病变 PCI 仍与不良预后相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Percutaneous coronary intervention outcomes based on American College of Cardiology/American Heart Association coronary lesion classification over 14 years – Melbourne interventional group (MIG) registry

Background

The American College of Cardiology / American Heart Association (ACC/AHA) introduced a coronary lesion classification in 1988 to stratify coronary lesions for probability of procedural success and complications after coronary angioplasty. Our aim is to assess the validity of the ACC/AHA lesion classification in predicting outcomes of percutaneous coronary intervention (PCI) in a contemporary cohort of patients.

Methods

Consecutive PCI procedures performed between 2005 and 2018, were divided into three periods. At each period, the ACC/AHA lesion classification (A, B1, B2, C) was analysed with respect to procedural characteristics, in-hospital and 30-day outcomes, as well as long-term mortality by linkage to the National Death Index (NDI).

Results

In total, 21,437 lesions were included with 7399 lesions (2005–2009), 6917 lesions (2010–2014) and 7121 lesions (2015–2018). There was a progressive increase in the number of complex lesions treated over time with ACC/AHA type C (15 %, 21 % and 26 %, p < 0.01). The rate of PCI procedural success decreased with increase in the complexity of lesions treated across all three periods (p < 0.01). Further, in-hospital and 30-day major adverse cardiovascular events (MACE), major adverse cardiac and cerebrovascular events (MACCE) increased across all three time periods (all p < 0.05).

Conclusions

Our study validates the ACC/AHA lesion classification as a meaningful tool for prediction of PCI outcomes. Despite advances in PCI techniques and technology, complex lesion PCI defined by this classification continues to be associated with adverse outcomes.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cardiovascular Revascularization Medicine
Cardiovascular Revascularization Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.30
自引率
5.90%
发文量
687
审稿时长
36 days
期刊介绍: Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, etc.
期刊最新文献
Safety and efficacy of the unilateral, suture-based, dry-closure technique in percutaneous trans-axillary aortic valve implantation. Outcomes of aortic stenosis in patients with cardiac amyloidosis: A systematic review and meta-analysis. The role of Pulmonary Artery Pulsatility Index to assess the outcomes following catheter directed therapy in patients with intermediate-to-high and high-risk pulmonary embolism. Sex-related differences in hospital outcomes after balloon aortic valvuloplasty. Clinical safety and performance of the third-generation Fantom Encore sirolimus-eluting bioresorbable scaffold: Insights from a single-center study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1